4.4 Article

Early antiretroviral therapy-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T-cell and B-cell memory

Journal

AIDS
Volume 34, Issue 5, Pages 669-680

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0000000000002485

Keywords

early treated children; gene expression; HIV-specific B cells; HIV-specific cell immunity; HIV-specific T cells; pediatric HIV; seronegative early treated children

Funding

  1. PENTA-ID foundation
  2. independent ViiV Healthcare UK grant
  3. CFAR [P30AI073961]
  4. NIAID
  5. NCI
  6. NICHD
  7. NHLBI
  8. NIDA
  9. NIMH
  10. NIA
  11. NIDDK
  12. NIGMS
  13. FIC
  14. OAR
  15. Children's Hospital Bambino Gesu
  16. Associazione Volontari Bambino Gesu
  17. National Institute of Health/National Institute of Allergy and Infectious Diseases Division of AIDS [U19AI118608]
  18. Department of Pediatrics, Boston Children's Hospital
  19. [AI12734704]
  20. [AI108472]
  21. [AI127347]

Ask authors/readers for more resources

Objective: To investigate long-term persistence of HIV-specific lymphocyte immunity in perinatally HIV-infected children treated within the first year of life. Design: Twenty perinatally HIV-infected children who received ART therapy within the first year of life (early treated) and with stable viral control (>5 years) were grouped according to their serological response to HIV. Methods: Western blot analysis and ELISA defined 14 HIV-seropositive and six seronegative patients. Frequencies of gp140-specific T-cell and B-cell, and T-cell cytokine production were quantified by flow cytometry in both seronegatives and seropositives. Transcriptional signatures in purified gp140-specific B-cell subsets, in response to in-vitro stimulation with HIV peptides was evaluated by multiplex RT-PCR. Results: Gp140-specific T cells and B cells persist at similar levels in both groups. A higher production of IL-21 in gp140-specific T cells was found in seropositives vs. seronegatives (P = 0.003). Gene expression in switched IgM-IgD- gp140-specific memory B cells after stimulation with HIV peptides in vitro demonstrated a differential expression of genes involved in signal transduction and activation after BCR/TLR triggering and B-cell activation. Genes relating to antibody production (PRDM1) and T-B cognate stimulation (CXCR4, IL21R) were differentially induced after in-vitro stimulation in seronegatives vs. seropositives suggesting a truncated process of B-cell maturation. Conclusion: HIV-specific memory B and T cells persist in early treated regardless their serological status. Seronegatives and seropositives are distinguished by gp140-specific T-cell function and by distinct transcriptional signatures of gp140-specific B cells after in-vitro stimulation, presumably because of a different antigen exposure. Such qualitative insights may inform future immunotherapeutic interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available